Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 35 Advanced Solid Tumors 20 Carcinoma, Non-Small-Cell Lung 14 Myelodysplastic Syndromes 13 Breast Neoplasms 13 Advanced Solid Tumor 13 Recurrence 10 Ovarian Neoplasms 8 Neoplasms 8 Multiple Myeloma 8 Leukemia, Myelomonocytic, Chronic 8 Triple Negative Breast Neoplasms 7 Solid Tumor 6 Myeloproliferative Disorders 6 Small Cell Lung Carcinoma 5 Prostatic Neoplasms 5 Neoplasm Metastasis 5 Lung Neoplasms 5 Carcinoma, Hepatocellular 5 Advanced Solid Tumour 5 Sarcoma 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Melanoma 4 Lymphoma, Large B-Cell, Diffuse 4 Lymphoma, B-Cell 4 Fallopian Tube Neoplasms 4 Colorectal Neoplasms 4 Advanced Malignant Solid Tumor 4 Advanced Lung Cancer 4 Squamous Cell Carcinoma of Head and Neck 3

Interventions

Gemcitabine 3 toripalimab 1 surufatinib 1 folfirinox 1 chloroquine diphosphate 1 balstilimab 1 Taxes 1 Paclitaxel 1 Oxaliplatin 1 Irinotecan 1 Injections 1 Immune Checkpoint Inhibitors 1 Drug Therapy 1 Cisplatin 1 Chloroquine 1 Celecoxib 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Pancreatic Cancer Metastatic × Injections × 1 year × Clear all

NCT06752811 2026-02-10

pompom

Shanghai Yizhong Pharmaceutical Co., Ltd.

Phase 3 Recruiting

Gastrointestinal

Pancreatic Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡